Alternative isoform regulation in human tissue transcriptomes, Nature, vol.456, pp.470-476, 2008. ,
The connection between splicing and cancer, J Cell Sci, vol.119, pp.2635-2641, 2006. ,
Aberrant and alternative splicing in cancer Cancer Res, vol.64, pp.7647-7654, 2004. ,
Splice variants as cancer biomarkers, Clin Biochem, vol.37, pp.584-94, 2004. ,
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer, Nucleic Acids Res, vol.36, pp.6535-6547, 2008. ,
Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer, Mol Cell Biol, vol.31, pp.138-150, 2011. ,
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptormediated apoptosis through specific downregulation of c-FLIP(short), Cell Death Differ, vol.13, pp.260-272, 2006. ,
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35, Cell Death Differ, vol.15, pp.1815-1823, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00360967
The transcription factor E2F1 and the SR protein SC35 control the ratio of proangiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo, Oncogene, vol.29, pp.5392-5403, 2010. ,
Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin, EMBO J, vol.30, pp.510-523, 2011. ,
Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers, Histopathology, vol.44, pp.54-63, 2004. ,
Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor, Cancer Res, vol.58, pp.1108-1110, 1998. ,
An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2, Oncogene, vol.20, pp.4041-4049, 2001. ,
Alternative splicing in lung cancer, J Thorac Oncol, vol.4, pp.674-678, 2009. ,
Insights into the connection between cancer and alternative splicing, Trends Genet, vol.24, pp.7-10, 2008. ,
Pre-mRNA splicing in the new millennium, Curr Opin Cell Biol, vol.13, pp.302-309, 2001. ,
The SR protein family of splicing factors: master regulators of gene expression, Biochem J, vol.417, pp.15-27, 2009. ,
SR proteins: a conserved family of pre-mRNA splicing factors, Genes Dev, vol.6, pp.837-847, 1992. ,
Specific interactions between proteins implicated in splice site selection and regulated alternative splicing, Cell, vol.75, pp.1061-1070, 1993. ,
Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2, EMBO J, vol.17, pp.6359-6367, 1998. ,
A serine kinase regulates intracellular localization of splicing factors in the cell cycle, Nature, vol.369, pp.678-82, 1994. ,
The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution, EMBO J, vol.15, pp.265-275, 1996. ,
CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles, J Cell Sci, vol.114, pp.2591-2603, 2001. ,
Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT, Nat Struct Mol Biol, vol.12, pp.1037-1044, 2005. ,
The gene encoding the splicing factor SF2/ASF is a proto-oncogene, Nat Struct Mol Biol, vol.14, pp.185-193, 2007. ,
The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression, Clin Cancer Res, vol.16, pp.4113-4125, 2010. ,
World Health Organization classification of tumours. Pathology and Genetics of tumours of the lung, pleura, thymus and heart, 2004. ,
A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm, Genes Dev, vol.12, pp.55-66, 1998. ,
Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer, Ann Thorac Surg, vol.92, pp.1794-1804, 2011. ,
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation, Nat Struct Mol Biol, vol.19, pp.220-228, 2012. ,
Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene, Mol Cell, vol.20, pp.881-890, 2005. ,
Regulation of apoptosis by alternative pre-mRNA splicing, Mol Cell, vol.19, pp.1-13, 2005. ,
Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors, PLoS One, vol.5, p.13690, 2010. ,
Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis, Oncogene, vol.18, pp.3574-3582, 1999. ,
Expression of splicing factors in human ovarian cancer, Oncol Rep, vol.11, pp.1085-1090, 2004. ,
RNA splicing factors regulated by HPV16 during cervical tumour progression, J Pathol, vol.219, pp.383-391, 2009. ,
Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma, Cancer Res, vol.66, pp.3819-3827, 2006. ,
Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas, Cancer Res, vol.67, pp.2072-2080, 2007. ,
Serine/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1, Cancer Res, vol.68, pp.4559-4570, 2008. ,
Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity, J Cell Biol, vol.138, pp.225-238, 1997. ,
Histology matters: individualizing treatment in non-small cell lung cancer, Oncologist, vol.15, pp.3-5, 2010. ,
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials, Ann Oncol, vol.21, pp.2023-2028, 2010. ,
The evolving role of histology in the management of advanced non-small-cell lung cancer, J Clin Oncol, vol.28, pp.5311-5320, 2010. ,
Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis, Mol Cell Biol, vol.27, pp.5393-5402, 2007. ,
Prometastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives, RNA Biol, vol.7, pp.495-503, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02193461